Skip to main content

Table 5 Factors associated with rtPA in the female dyslipidemic stroke population.

From: Gender and thrombolysis therapy in stroke patients with incidence of dyslipidemia

 

B Value

Wald

Odds Ratio

95% C.I.

Lower

For OR

Upper

P Value

Age

0.023

4.109

1.024

1.001

1.047

0.043*

BMI

-0.001

0.006

0.999

0.967

1.031

0.940

NIH Stroke Scale

-0.120

7.713

0.887

0.815

0.965

0.005*

Risk of Mortality GWTG

0.068

1.518

1.070

0.961

1.193

0.218

Race

0.108

0.147

1.115

0.640

1.940

0.701

Atrial Fibrillation

0.387

1.295

1.473

0.756

2.871

0.255

Coronary Artery Disease

0.404

1.910

1.498

0.845

2.655

0.167

Carotid Artery Stenosis

1.955

6.145

7.063

1.506

33.134

0.013*

Diabetes

1.001

3.377

2.720

0.936

7.909

0.066

Congestive Heart Failure

0.216

0.331

1.242

0.594

2.596

0.565

Hypertension

-0.049

0.010

0.952

0.369

2.456

0.919

Previous Stroke

0.682

5.820

1.978

1.136

3.442

0.016*

Previous TIA

-0.338

0.686

0.713

0.320

1.588

0.407

Peripheral Vascular Disease

-0.356

0.688

0.700

0.302

1.625

0.407

History of Smoking

-0.296

0.745

0.744

0.379

1.458

0.388

Antiplatelet medication

-0.043

0.024

0.958

0.556

1.650

0.877

Antihypertensive medication

-1.057

5.572

0.347

0.144

0.836

0.018*

Cholesterol Reducer

-0.182

0.384

0.834

0.469

1.482

0.535

Antidiabetic medication

-0.627

1.236

0.534

0.177

1.613

0.266

  1. Positive B values (Adj, OR > 1) denote variables more associated with rtPA exclusion while negative B values (Adj. OR < 1) denote variables more associated with rtPA inclusion. Multicollinearity and interactions among independent variables were checked. Hosmer-Lemeshow test (P = 0.102), Classification table (overall correctly classified percentage = 66.9%), and area under the ROC curve (AUC = 0.708) were applied to check the model fitness